Trail Ridge Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Sell |
3,721
-145
| -4% | -$67.8K | 0.84% | 31 |
|
|
2025
Q1 | $1.92M | Sell |
3,866
-181
| -4% | -$90.1K | 0.99% | 26 |
|
|
2024
Q4 | $2.11M | Sell |
4,047
-101
| -2% | -$52.5K | 1% | 28 |
|
|
2024
Q3 | $2.39M | Sell |
4,148
-30
| -0.7% | -$17.3K | 1.14% | 24 |
|
|
2024
Q2 | $2.31M | Sell |
4,178
-16
| -0.4% | -$8.85K | 1.19% | 24 |
|
|
2024
Q1 | $2.44M | Buy |
4,194
+180
| +4% | +$105K | 1.38% | 21 |
|
|
2023
Q4 | $2.13M | Sell |
4,014
-38
| -0.9% | -$20.2K | 1.31% | 21 |
|
|
2023
Q3 | $2.05M | Buy |
4,052
+43
| +1% | +$21.8K | 1.39% | 19 |
|
|
2023
Q2 | $2.09M | Sell |
4,009
-53
| -1% | -$27.7K | 1.29% | 24 |
|
|
2023
Q1 | $2.34M | Buy |
4,062
+200
| +5% | +$115K | 1.53% | 14 |
|
|
2022
Q4 | $2.13M | Hold |
3,862
| – | – | 1.46% | 17 |
|
|
2022
Q3 | $2.08M | Hold |
3,862
| – | – | 1.37% | 16 |
|
|
2022
Q2 | $2.1M | Sell |
3,862
-30
| -0.8% | -$16.3K | 1.42% | 16 |
|
|
2022
Q1 | $2.3M | Sell |
3,892
-40
| -1% | -$23.6K | 1.41% | 13 |
|
|
2021
Q4 | $2.62M | Buy |
+3,932
| New | +$2.62M | 1.58% | 12 |
|